PubMed:8522361
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 77-82 | DNA | denotes | c-fos |
| T2 | 86-104 | cell_line | denotes | B and T cell lines |
| T3 | 122-127 | DNA | denotes | c-fos |
| T4 | 140-162 | protein | denotes | surface immunoglobulin |
| T5 | 167-191 | protein | denotes | T cell antigen receptors |
| T6 | 211-230 | DNA | denotes | protooncogene c-fos |
| T7 | 289-297 | protein | denotes | kinase C |
| T8 | 318-326 | protein | denotes | Kinase C |
| T9 | 371-392 | protein | denotes | serum response factor |
| T10 | 394-397 | protein | denotes | SRF |
| T11 | 424-446 | DNA | denotes | serum response element |
| T12 | 448-451 | DNA | denotes | SRE |
| T13 | 516-520 | protein | denotes | CREB |
| T14 | 522-561 | protein | denotes | cAMP regulatory element binding protein |
| T15 | 593-609 | protein | denotes | protein kinase A |
| T16 | 613-640 | protein | denotes | calmodulin-regulated kinase |
| T17 | 693-717 | cell_line | denotes | Burkitt's lymphoma cells |
| T18 | 719-724 | cell_line | denotes | Ramos |
| T19 | 729-734 | cell_line | denotes | Daudi |
| T20 | 749-772 | cell_line | denotes | T lymphocytic cell line |
| T21 | 774-780 | cell_line | denotes | Jurkat |
| T22 | 876-881 | DNA | denotes | c-fos |
| T23 | 902-910 | protein | denotes | kinase C |
| T24 | 1048-1053 | DNA | denotes | c-fos |
| T25 | 1130-1135 | DNA | denotes | c-fos |
| T26 | 1216-1221 | DNA | denotes | c-fos |
| T27 | 1304-1309 | cell_line | denotes | Ramos |
| T28 | 1311-1318 | cell_type | denotes | B cells |
| T29 | 1324-1330 | cell_line | denotes | Jurkat |
| T30 | 1332-1339 | cell_type | denotes | T cells |
| T31 | 1362-1367 | DNA | denotes | c-fos |
| T32 | 1421-1427 | cell_line | denotes | Jurkat |
| T33 | 1453-1458 | cell_line | denotes | Ramos |
| T34 | 1472-1476 | protein | denotes | AP-1 |
| T35 | 1564-1574 | RNA | denotes | c-fos mRNA |
| T36 | 1644-1648 | protein | denotes | AP-1 |
| T37 | 1672-1679 | cell_type | denotes | B cells |
| T38 | 1687-1694 | protein | denotes | anti-Ig |
| T39 | 1721-1729 | protein | denotes | kinase C |
| T40 | 1794-1804 | RNA | denotes | c-fos mRNA |
| T41 | 1862-1870 | protein | denotes | kinase C |
| T42 | 1918-1923 | DNA | denotes | c-fos |
| T43 | 1975-1980 | DNA | denotes | c-fos |
| T44 | 2042-2049 | protein | denotes | anti-Ig |
| T45 | 2063-2068 | DNA | denotes | c-fos |
| T46 | 2153-2160 | protein | denotes | anti-Ig |
| T47 | 2174-2179 | DNA | denotes | c-fos |
| T48 | 2271-2276 | DNA | denotes | c-fos |
| T49 | 2311-2316 | DNA | denotes | c-fos |
| T50 | 2333-2363 | protein | denotes | B and T cell antigen receptors |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 16-44 | other_name | denotes | signal transduction pathways |
| T2 | 77-82 | DNA_domain_or_region | denotes | c-fos |
| T3 | 122-127 | DNA_domain_or_region | denotes | c-fos |
| T4 | 140-162 | protein_family_or_group | denotes | surface immunoglobulin |
| T5 | 167-191 | protein_family_or_group | denotes | T cell antigen receptors |
| T6 | 211-224 | DNA_family_or_group | denotes | protooncogene |
| T7 | 225-230 | DNA_domain_or_region | denotes | c-fos |
| T8 | 259-278 | other_name | denotes | regulatory pathways |
| T9 | 289-297 | protein_molecule | denotes | kinase C |
| T10 | 299-303 | nucleotide | denotes | cAMP |
| T11 | 309-316 | atom | denotes | calcium |
| T12 | 318-326 | protein_family_or_group | denotes | Kinase C |
| T13 | 352-367 | other_name | denotes | phosphorylation |
| T14 | 371-392 | protein_molecule | denotes | serum response factor |
| T15 | 394-397 | protein_molecule | denotes | SRF |
| T16 | 424-446 | DNA_domain_or_region | denotes | serum response element |
| T17 | 448-451 | DNA_domain_or_region | denotes | SRE |
| T18 | 454-458 | nucleotide | denotes | cAMP |
| T19 | 463-470 | atom | denotes | calcium |
| T20 | 497-512 | other_name | denotes | phosphorylation |
| T21 | 516-520 | protein_molecule | denotes | CREB |
| T22 | 522-526 | nucleotide | denotes | cAMP |
| T23 | 593-609 | protein_molecule | denotes | protein kinase A |
| T24 | 613-640 | protein_family_or_group | denotes | calmodulin-regulated kinase |
| T25 | 693-717 | cell_line | denotes | Burkitt's lymphoma cells |
| T26 | 719-724 | cell_line | denotes | Ramos |
| T27 | 729-734 | cell_line | denotes | Daudi |
| T28 | 749-772 | cell_line | denotes | T lymphocytic cell line |
| T29 | 774-780 | cell_line | denotes | Jurkat |
| T30 | 876-881 | DNA_domain_or_region | denotes | c-fos |
| T31 | 902-910 | protein_molecule | denotes | kinase C |
| T32 | 923-926 | other_organic_compound | denotes | PMA |
| T33 | 961-965 | nucleotide | denotes | cAMP |
| T34 | 967-985 | other_organic_compound | denotes | forskolin plus MIX |
| T35 | 990-997 | atom | denotes | calcium |
| T36 | 1011-1020 | other_name | denotes | ionophore |
| T37 | 1048-1053 | DNA_domain_or_region | denotes | c-fos |
| T38 | 1078-1082 | nucleotide | denotes | cAMP |
| T39 | 1102-1109 | atom | denotes | calcium |
| T40 | 1130-1135 | DNA_domain_or_region | denotes | c-fos |
| T41 | 1147-1159 | other_organic_compound | denotes | Okadaic acid |
| T42 | 1216-1221 | DNA_domain_or_region | denotes | c-fos |
| T43 | 1270-1274 | nucleotide | denotes | cAMP |
| T44 | 1304-1309 | cell_line | denotes | Ramos |
| T45 | 1311-1318 | cell_type | denotes | B cells |
| T46 | 1324-1330 | cell_line | denotes | Jurkat |
| T47 | 1332-1339 | cell_type | denotes | T cells |
| T48 | 1362-1367 | DNA_domain_or_region | denotes | c-fos |
| T49 | 1376-1380 | nucleotide | denotes | cAMP |
| T50 | 1386-1393 | atom | denotes | calcium |
| T51 | 1421-1427 | cell_line | denotes | Jurkat |
| T52 | 1453-1458 | cell_line | denotes | Ramos |
| T53 | 1472-1476 | protein_molecule | denotes | AP-1 |
| T54 | 1492-1517 | other_name | denotes | gel mobility shift assays |
| T55 | 1564-1569 | DNA_domain_or_region | denotes | c-fos |
| T56 | 1644-1648 | protein_molecule | denotes | AP-1 |
| T57 | 1672-1679 | cell_type | denotes | B cells |
| T58 | 1687-1694 | protein_family_or_group | denotes | anti-Ig |
| T59 | 1721-1729 | protein_molecule | denotes | kinase C |
| T60 | 1770-1777 | atom | denotes | calcium |
| T61 | 1794-1799 | DNA_domain_or_region | denotes | c-fos |
| T62 | 1862-1870 | protein_molecule | denotes | kinase C |
| T63 | 1886-1893 | atom | denotes | calcium |
| T64 | 1918-1923 | DNA_domain_or_region | denotes | c-fos |
| T65 | 1975-1980 | DNA_domain_or_region | denotes | c-fos |
| T66 | 2042-2049 | protein_family_or_group | denotes | anti-Ig |
| T67 | 2063-2068 | DNA_domain_or_region | denotes | c-fos |
| T68 | 2099-2103 | nucleotide | denotes | cAMP |
| T69 | 2153-2160 | protein_family_or_group | denotes | anti-Ig |
| T70 | 2174-2179 | DNA_domain_or_region | denotes | c-fos |
| T71 | 2271-2276 | DNA_domain_or_region | denotes | c-fos |
| T72 | 2311-2316 | DNA_domain_or_region | denotes | c-fos |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-192 | Sentence | denotes | Synergy between signal transduction pathways is obligatory for expression of c-fos in B and T cell lines: implication for c-fos control via surface immunoglobulin and T cell antigen receptors. |
| S2 | 193-317 | Sentence | denotes | Expression of the protooncogene c-fos is controlled by three main regulatory pathways involving kinase C, cAMP, and calcium. |
| S3 | 318-641 | Sentence | denotes | Kinase C mediates its effects via phosphorylation of serum response factor (SRF) which interacts with the serum response element (SRE); cAMP and calcium mediate their effects via phosphorylation of CREB (cAMP regulatory element binding protein) presumably by activation of a protein kinase A or calmodulin-regulated kinase. |
| S4 | 642-782 | Sentence | denotes | We have examined the function of these elements in Burkitt's lymphoma cells (Ramos and Daudi) as well as a T lymphocytic cell line (Jurkat). |
| S5 | 783-892 | Sentence | denotes | We have found that stimulation of any one of these pathways alone has little or no effect on c-fos induction. |
| S6 | 893-1064 | Sentence | denotes | However, kinase C activation (PMA stimulation) combined with either cAMP (forskolin plus MIX) or calcium stimulation (ionophore) leads to greatly enhanced c-fos induction. |
| S7 | 1065-1146 | Sentence | denotes | By contrast, cAMP in the presence of calcium shows no synergy in c-fos induction. |
| S8 | 1147-1275 | Sentence | denotes | Okadaic acid augments PMA- as well as calcium-mediated activation of c-fos, and has little or no effect when combined with cAMP. |
| S9 | 1276-1459 | Sentence | denotes | The main difference between Ramos (B cells) and Jurkat (T cells) in the regulation of c-fos is that cAMP plus calcium is strongly synergistic in Jurkat and is without effect in Ramos. |
| S10 | 1460-1658 | Sentence | denotes | Analysis of AP-1 activity using gel mobility shift assays confirms that the requirements for synergy in c-fos mRNA induction are paralleled by requirements for synergy in induction of AP-1 activity. |
| S11 | 1659-1815 | Sentence | denotes | Signaling in B cells due to anti-Ig stimulation involves both kinase C activation and release of intracellular calcium, and results in c-fos mRNA induction. |
| S12 | 1816-1986 | Sentence | denotes | Our results indicate that synergy between the kinase C activation and calcium is needed for efficient c-fos induction since neither of these two alone induces c-fos well. |
| S13 | 1987-2180 | Sentence | denotes | That synergy of signaling pathways is relevant for the anti-Ig induction of c-fos is supported by the fact that cAMP-inducing agents and okadaic acid further enhance anti-Ig induction of c-fos. |
| S14 | 2181-2364 | Sentence | denotes | These results suggest that cell-specific patterns of synergy are an essential feature for c-fos induction and may be relevant for c-fos control through B and T cell antigen receptors. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-44 | NP | denotes | Synergy between signal transduction pathways |
| C3 | 77-82 | NP | denotes | c-fos |
| C2 | 63-82 | NP | denotes | expression of c-fos |
| C4 | 122-135 | NP | denotes | c-fos control |
| C5 | 140-191 | NP | denotes | surface immunoglobulin and T cell antigen receptors |
| C7 | 207-230 | NP | denotes | the protooncogene c-fos |
| C6 | 193-230 | NP | denotes | Expression of the protooncogene c-fos |
| C9 | 289-297 | NP | denotes | kinase C |
| C10 | 299-316 | NP | denotes | cAMP, and calcium |
| C8 | 248-316 | NP | denotes | three main regulatory pathways involving kinase C, cAMP, and calcium |
| C11 | 318-326 | NP | denotes | Kinase C |
| C12 | 336-339 | NP | denotes | its |
| C13 | 371-398 | NP | denotes | serum response factor (SRF) |
| C14 | 399-404 | NP | denotes | which |
| C15 | 454-470 | NP | denotes | cAMP and calcium |
| C16 | 479-484 | NP | denotes | their |
| C17 | 693-735 | NP | denotes | Burkitt's lymphoma cells (Ramos and Daudi) |
| C18 | 747-781 | NP | denotes | a T lymphocytic cell line (Jurkat) |
| C19 | 828-842 | NP | denotes | these pathways |
| C20 | 876-891 | NP | denotes | c-fos induction |
| C21 | 902-939 | NP | denotes | kinase C activation (PMA stimulation) |
| C22 | 1078-1082 | NP | denotes | cAMP |
| C23 | 1102-1109 | NP | denotes | calcium |
| C24 | 1130-1145 | NP | denotes | c-fos induction |
| C25 | 1147-1159 | NP | denotes | Okadaic acid |
| C26 | 1216-1221 | NP | denotes | c-fos |
| C27 | 1270-1274 | NP | denotes | cAMP |
| C28 | 1304-1319 | NP | denotes | Ramos (B cells) |
| C29 | 1324-1340 | NP | denotes | Jurkat (T cells) |
| C30 | 1362-1367 | NP | denotes | c-fos |
| C31 | 1376-1380 | NP | denotes | cAMP |
| C32 | 1386-1393 | NP | denotes | calcium |
| C33 | 1421-1427 | NP | denotes | Jurkat |
| C34 | 1453-1458 | NP | denotes | Ramos |
| C35 | 1564-1584 | NP | denotes | c-fos mRNA induction |
| C36 | 1672-1679 | NP | denotes | B cells |
| C37 | 1721-1740 | NP | denotes | kinase C activation |
| C38 | 1794-1814 | NP | denotes | c-fos mRNA induction |
| C40 | 1858-1881 | NP | denotes | the kinase C activation |
| C41 | 1886-1893 | NP | denotes | calcium |
| C39 | 1842-1893 | NP | denotes | synergy between the kinase C activation and calcium |
| C42 | 1908-1933 | NP | denotes | efficient c-fos induction |
| C43 | 1975-1980 | NP | denotes | c-fos |
| C44 | 1992-2021 | NP | denotes | synergy of signaling pathways |
| C46 | 2063-2068 | NP | denotes | c-fos |
| C45 | 2038-2068 | NP | denotes | the anti-Ig induction of c-fos |
| C47 | 2085-2093 | NP | denotes | the fact |
| C48 | 2094-2098 | NP | denotes | that |
| C49 | 2124-2136 | NP | denotes | okadaic acid |
| C51 | 2174-2179 | NP | denotes | c-fos |
| C50 | 2153-2179 | NP | denotes | anti-Ig induction of c-fos |
| C52 | 2271-2286 | NP | denotes | c-fos induction |
| C53 | 2311-2324 | NP | denotes | c-fos control |
| C54 | 2333-2363 | NP | denotes | B and T cell antigen receptors |
| R1 | C7 | C3 | coref-ident | the protooncogene c-fos,c-fos |
| R2 | C6 | C2 | coref-ident | Expression of the protooncogene c-fos,expression of c-fos |
| R3 | C11 | C9 | coref-ident | Kinase C,kinase C |
| R4 | C12 | C11 | coref-pron | its,Kinase C |
| R5 | C14 | C13 | coref-relat | which,serum response factor (SRF) |
| R6 | C15 | C10 | coref-ident | cAMP and calcium,"cAMP, and calcium" |
| R7 | C16 | C15 | coref-pron | their,cAMP and calcium |
| R8 | C19 | C8 | coref-ident | these pathways,"three main regulatory pathways involving kinase C, cAMP, and calcium" |
| R9 | C24 | C20 | coref-ident | c-fos induction,c-fos induction |
| R10 | C26 | C7 | coref-ident | c-fos,the protooncogene c-fos |
| R11 | C27 | C22 | coref-ident | cAMP,cAMP |
| R12 | C28 | C17 | coref-ident | Ramos (B cells),Burkitt's lymphoma cells (Ramos and Daudi) |
| R13 | C29 | C18 | coref-ident | Jurkat (T cells),a T lymphocytic cell line (Jurkat) |
| R14 | C30 | C2 | coref-ident | c-fos,expression of c-fos |
| R15 | C31 | C27 | coref-ident | cAMP,cAMP |
| R16 | C32 | C23 | coref-ident | calcium,calcium |
| R17 | C33 | C29 | coref-ident | Jurkat,Jurkat (T cells) |
| R18 | C34 | C28 | coref-ident | Ramos,Ramos (B cells) |
| R19 | C36 | C28 | coref-ident | B cells,Ramos (B cells) |
| R20 | C37 | C21 | coref-ident | kinase C activation,kinase C activation (PMA stimulation) |
| R21 | C38 | C35 | coref-ident | c-fos mRNA induction,c-fos mRNA induction |
| R22 | C40 | C37 | coref-ident | the kinase C activation,kinase C activation |
| R23 | C41 | C32 | coref-ident | calcium,calcium |
| R24 | C43 | C30 | coref-ident | c-fos,c-fos |
| R25 | C44 | C1 | coref-ident | synergy of signaling pathways,Synergy between signal transduction pathways |
| R26 | C46 | C43 | coref-ident | c-fos,c-fos |
| R27 | C48 | C47 | coref-relat | that,the fact |
| R28 | C49 | C25 | coref-ident | okadaic acid,Okadaic acid |
| R29 | C51 | C46 | coref-ident | c-fos,c-fos |
| R30 | C50 | C45 | coref-ident | anti-Ig induction of c-fos,the anti-Ig induction of c-fos |
| R31 | C52 | C42 | coref-ident | c-fos induction,efficient c-fos induction |
| R32 | C53 | C4 | coref-ident | c-fos control,c-fos control |
| R33 | C54 | C5 | coref-ident | B and T cell antigen receptors,surface immunoglobulin and T cell antigen receptors |